Researchers study power failures in prosthetics
Researchers have identified reasons for power failures in prosthetics worn by amputees, which could help in future design work. Read more and read the…
Web Exclusives
ECRI announces top technology hazards for 2015
The ECRI Institute has announced its Top 10 Health Technology Hazards for 2015, which include alarm hazards, mix-up of IV lines, lack of data…
High consumption of trans fat diminishes memory
A study presented at the American Heart Association Scientific Sessions 2014 found that high trans fat consumption is linked to worse memory among working-age…
‘Smart’ drug not beneficial
The “smart” drug Modafinil, which many students take to improve their ability to study and increase exam success does not increase cognition and slows…
Bariatric surgeries compared
According to a study in JAMA Surgery, laparoscopic Roux-en-Y gastric bypass results in much greater weight loss and fewer reoperations compared to laparoscopic adjustable…
New guidelines for treating cancer of the esophagus
The November 2014 issue of The Annals of Thoracic Surgery includes practice guidelines on the use of multimodality treatment for cancer of the esophagus…
Improved patient handoffs reduces medical errors
Improved patient handoffs using the I-PASS bundle reduces medical errors by 30%, according to a study in the New England Journal of Medicine (NEJM).…
Drugs for diabetic neuropathy similarly effective despite cost differences
Drugs for managing diabetic neuropathy are similarly effective, yet the costs of these drugs vary greatly, according to a study in the Annals of…
FDA approves vaccine for meningococcal disease
On Oct. 29, the U.S. Food and Drug Administration (FDA) approved Trumenba, the first vaccine licensed in the United States to prevent invasive meningococcal…
Ebola resources
Access ebola-related resources from Nebraska Medicine and the American Nurses Association.
FDA approves new labeling for Embeda ER capsules
On Oct. 17, the U.S. Food and Drug Administration (FDA) approved new labeling for Embeda (morphine sulfate and naltrexone hydrochloride) extended-release (ER) capsules, an…
Staggering number of alarms identified
A study in PLOS ONE found more than 2.5 million patient monitoring alarms in one month in one hospital. Many were caused by a…
Researchers study power failures in prosthetics
Researchers have identified reasons for power failures in prosthetics worn by amputees, which could help in future design work. Read more and…
ECRI announces top technology hazards for 2015
The ECRI Institute has announced its Top 10 Health Technology Hazards for 2015, which include alarm hazards, mix-up of IV lines, lack…
High consumption of trans fat diminishes memory
A study presented at the American Heart Association Scientific Sessions 2014 found that high trans fat consumption is linked to worse memory…
‘Smart’ drug not beneficial
The “smart” drug Modafinil, which many students take to improve their ability to study and increase exam success does not increase cognition…
Bariatric surgeries compared
According to a study in JAMA Surgery, laparoscopic Roux-en-Y gastric bypass results in much greater weight loss and fewer reoperations compared to…
New guidelines for treating cancer of the esophagus
The November 2014 issue of The Annals of Thoracic Surgery includes practice guidelines on the use of multimodality treatment for cancer of…
Improved patient handoffs reduces medical errors
Improved patient handoffs using the I-PASS bundle reduces medical errors by 30%, according to a study in the New England Journal of…
Drugs for diabetic neuropathy similarly effective despite cost differences
Drugs for managing diabetic neuropathy are similarly effective, yet the costs of these drugs vary greatly, according to a study in the…
FDA approves vaccine for meningococcal disease
On Oct. 29, the U.S. Food and Drug Administration (FDA) approved Trumenba, the first vaccine licensed in the United States to prevent…
Ebola resources
Access ebola-related resources from Nebraska Medicine and the American Nurses Association.
FDA approves new labeling for Embeda ER capsules
On Oct. 17, the U.S. Food and Drug Administration (FDA) approved new labeling for Embeda (morphine sulfate and naltrexone hydrochloride) extended-release (ER)…
Staggering number of alarms identified
A study in PLOS ONE found more than 2.5 million patient monitoring alarms in one month in one hospital. Many were caused…
Poll
Preferred way to get content
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.